DIR Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
HTML https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: TYSABRI (natalizumab)
*****************************************************
#Post#: 454--------------------------------------------------
Massive MS exacerbation after withdrawal & early restart of
Tysabri
By: agate Date: September 2, 2014, 8:10 pm
---------------------------------------------------------
This is just one case but it seems significant enough to
mention. From DocGuide/Neurology, September 2, 2014:
[quote]Source: J Clin Neurosci
Massive exacerbation of multiple sclerosis after withdrawal and
early restart of treatment with natalizumab
Beume L, Dersch R, Fuhrer H, Stich O, Rauer S, Niesen W;
Journal of Clinical Neuroscience (Aug 2014)
We present a 46-year-old woman with a relapse of multiple
sclerosis (MS) that began 3 months after withdrawal from
long-term treatment with natalizumab. Shortly after restart of a
single dose of natalizumab she developed a fulminant MS rebound
with stupor and tetraparesis. Cerebral MRI showed massive
progression in the number of lesions and tumefactive lesions
with ring gadolinium-enhancement. Stereotactic brain biopsy
revealed acute demyelination and B-cell dominated inflammation.
The patient improved during therapeutic plasma exchange.
We speculate that early restart of natalizumab in the case of a
relapse may worsen disease evolution possibly by modifying
regulatory immune effector processes during an inflammatory
rebound phase. A restart of natalizumab in MS patients suffering
from a recent relapse or with signs of active inflammation
should be considered with caution.[/quote]
This article summary can be seen here
HTML http://www.docguide.com/massive-exacerbation-multiple-sclerosis-after-withdrawal-and-early-restart-treatment-natalizumab?hash=544098a8&eid=40678&alrhash=2e22ec-4b70c95432d7b63d98dcc4c365f92710.
*****************************************************